Aryaman Capital Markets net profit falls 29% to ₹783 lakh in Q1FY26

2 min read     Updated on 11 Aug 2026, 10:08 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Aryaman Capital Markets posted a net profit of ₹783.01 lakh in Q1FY26, down 29% from ₹1,103.21 lakh in Q1FY25, as revenue from operations fell sharply by 64% to ₹927.88 lakh. The Board approved the unaudited results on August 10, 2026, noting a significant reduction in expenses due to the absence of inventory-related costs seen in the prior year.

powered bylight_fuzz_icon
47927372

*this image is generated using AI for illustrative purposes only.

Aryaman Capital Markets reported a significant year-on-year decline in profitability and revenue for the quarter ended June 30, 2026, signaling continued pressure on its financial services business. Net profit from continuing operations fell 29% to ₹783.01 lakh, down from ₹1,103.21 lakh in the corresponding quarter of the previous year. Revenue from operations contracted sharply by 64% to ₹927.88 lakh, compared to ₹2,572.22 lakh in Q1FY25, reflecting a substantial reduction in top-line activity.

The Board of Directors approved the unaudited financial results on August 10, 2026, during a meeting that also covered material related-party transactions and the notice for the 18th Annual General Meeting (AGM) scheduled for September 2, 2026. The results were prepared in compliance with Indian Accounting Standards (Ind-AS) and subjected to a limited review by statutory auditors V.N. Purohit & Co., Chartered Accountants. The firm issued a clean review report, stating that nothing came to their attention to suggest the statement contained material misstatements or failed to disclose required information under SEBI Listing Regulations.

Q1FY26 Financial Performance

The company’s total income for the quarter stood at ₹950.23 lakh, comprising ₹927.88 lakh from operations and ₹22.36 lakh from other income. Total expenses remained controlled at ₹26.78 lakh, a significant decrease from ₹1,337.85 lakh in the prior year period, primarily due to the absence of stock-in-trade purchases and inventory changes which had impacted the previous year’s figures.

Metric Q1FY26 (₹ Lakh) Q1FY25 (₹ Lakh) YoY Change
Revenue from Operations 927.88 2,572.22 -64%
Other Income 22.36 46.60 -52%
Total Expenses 26.78 1,337.85 -98%
Profit Before Tax 923.45 1,280.98 -28%
Net Profit After Tax 783.01 1,103.21 -29%

Tax expenses for the quarter amounted to ₹140.44 lakh, including current tax of ₹31.92 lakh and deferred tax of ₹108.52 lakh. Earnings per share (basic and diluted) were reported at ₹6.54, down from ₹9.21 in the same quarter last year. The company operates exclusively in the Financial Services segment.

Corporate Governance and AGM Details

Alongside the financial results, the Board approved the appointment of M/s. JNG&CO.LLP as the scrutinizer for the upcoming 18th AGM. The meeting will be held via Video Conferencing on September 2, 2026. The Board also reviewed material transactions with related parties as mandated under the Companies Act, 2013, and SEBI Listing Regulations. Reenal Khandelwal, Company Secretary and Compliance Officer, signed the disclosure letter submitted to BSE Limited on August 10, 2026.

What the Numbers Show

The sharp divergence between the 64% revenue drop and the 29% profit decline highlights a structural shift in cost dynamics rather than pure operational efficiency. In Q1FY25, high expenses related to inventory management (₹1,086.98 lakh combined for purchase and changes in inventories) heavily weighed on the bottom line. With these costs absent in Q1FY26, total expenses plummeted to ₹26.78 lakh. However, the core revenue generation capability has weakened significantly, suggesting that while the cost base is leaner, the primary business engine is generating substantially less volume than the previous year.

Historical Stock Returns for Aryaman Capital Markets

1 Day5 Days1 Month6 Months1 Year5 Years
-4.64%+0.56%-1.74%-18.26%-0.60%+878.14%

What specific strategic initiatives is Aryaman Capital Markets planning to implement to reverse the 64% decline in operational revenue?

How might the absence of inventory-related expenses in Q1FY26 distort the true picture of the company's operational efficiency compared to previous years?

Will management address concerns regarding the sustainability of current profit margins given the significant contraction in top-line activity at the upcoming AGM?

Aryaman Capital Markets
View Company Insights
View All News
like15
dislike

Aryaman Capital Markets appoints Ronak Jain as independent director

2 min read     Updated on 31 Jul 2026, 11:36 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Aryaman Capital Markets Ltd has appointed Ronak Jain as an Additional Non-Executive Independent Director for a five-year term starting July 31, 2026, subject to shareholder approval. Simultaneously, Darshit Parikh ceased his role after completing two consecutive terms. The Nomination and Remuneration Committee was restructured with Kajal Chhatwal as Chairperson, Damini Baid as Member, and Ronak Jain as Member.

powered bylight_fuzz_icon
47022748

*this image is generated using AI for illustrative purposes only.

Aryaman Capital Markets has appointed Ronak Jain as an Additional Non-Executive Independent Director for a five-year term, effective July 31, 2026. The appointment, approved by the Board of Directors at a meeting held on July 31, 2026, is subject to shareholder approval at the ensuing general meeting. This governance change coincides with the cessation of Darshit Parikh, who ceases to hold office on the same date upon completing his second consecutive term as a Non-Executive Independent Director.

The Board also reconstituted its Nomination and Remuneration Committee to reflect these changes. The restructured committee comprises Ms. Kajal Chhatwal as Chairperson, alongside Ms. Damini Baid and Mr. Ronak Jain as members. All three hold the designation of Non-Executive Independent Director.

Board Meeting Details

The Board of Directors convened on July 31, 2026, from 10:30 A.M. to 11:00 A.M. to approve these appointments and structural adjustments. The decisions were made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015.

The company confirmed that Mr. Ronak Jain is not debarred from holding director office by any order issued by SEBI or other authorities, in compliance with Stock Exchange circulars.

Director Profiles and Disclosures

Mr. Ronak Rajendra Jain brings over a decade of experience in audit, taxation, financial reporting, regulatory compliance, corporate governance, and investment banking. He serves as the Proprietor of M/s. Ronak Jain & Associates and is a Partner at M/s. SSKA & Co., Chartered Accountants. Mr. Jain holds a Bachelor's degree in Commerce and is a Certified Information Systems Auditor (CISA). He is registered with the Independent Director Databank maintained by the Indian Institute of Corporate Affairs (IICA).

Disclosures indicate that Mr. Jain is not related to any existing Directors of the Company. He holds an interest in Escorp Asset Management Limited.

Committee Composition

The reconstituted Nomination and Remuneration Committee is structured as follows:

Sr. No. Committee Members Designation Position in Committee
1. Ms. Kajal Chhatwal Non-Executive Independent Director Chairperson
2. Ms. Damini Baid Non-Executive Independent Director Member
3. Mr. Ronak Jain Non-Executive Independent Director Member

Regulatory Compliance

The disclosures regarding the appointment and cessation were furnished in accordance with Regulation 30 read with Paragraph A of Part A of Schedule III of the SEBI Listing Regulations. The company also cited compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Reenal Khandelwal, Company Secretary and Compliance Officer, signed the disclosure documents submitted to BSE Limited.

Historical Stock Returns for Aryaman Capital Markets

1 Day5 Days1 Month6 Months1 Year5 Years
-4.64%+0.56%-1.74%-18.26%-0.60%+878.14%

How might Ronak Jain's background in audit and regulatory compliance influence Aryaman Capital Markets' approach to upcoming SEBI regulatory changes?

What strategic shifts in executive remuneration or board nomination policies could result from the restructured Nomination and Remuneration Committee?

Will the transition from Darshit Parikh to Ronak Jain signal a change in the company's governance philosophy or risk management priorities?

Aryaman Capital Markets
View Company Insights
View All News
like19
dislike

More News on Aryaman Capital Markets

1 Year Returns:-0.60%